Electric Medicine attracting investment and driving strategic acquisitions

Electric medicine, a sub-sector of healthtech, is a rapidly growing field that uses electrical energy to treat diseases and conditions. This trend is attracting significant investment from venture capital firms and is driving strategic acquisitions within the medical technology (medtech) industry. 

⚡️ What is Electric Medicine?

Electric medicine, also known as bioelectric medicine or electroceuticals, involves using electrical impulses to stimulate or block nerve signals to treat a variety of conditions. Instead of traditional pharmaceuticals, these treatments use devices that interface with the body's nervous system.

Key applications include:

Pain management: Devices like Transcutaneous Electrical Nerve Stimulation (TENS) units for chronic pain relief.

Neurological disorders: Deep brain stimulators for conditions like Parkinson's disease and epilepsy.

Cardiology: Implantable cardioverter-defibrillators (ICDs) and pacemakers for heart rhythm disorders.

Mental health: Electroconvulsive therapy (ECT) and vagus nerve stimulation for severe depression.

💰 Increasing Venture Capital Investment

While overall venture capital funding in healthtech has experienced some fluctuations, investment in specific, high-growth areas like electric medicine and AI-driven solutions is surging. The market for bioelectric medicine was valued at over $21 billion in 2022 and is projected to reach over $35 billion by 2030. This growth is driven by the rising prevalence of chronic conditions and an aging population.

Venture capitalists are drawn to electric medicine for several reasons:

Proven Technology: Many of these devices, such as pacemakers, have long-standing clinical validation.

Non-invasive Potential: The development of non-invasive electroceuticals is a particularly attractive area for investment.

Regulatory Pathway: Unlike drug development, which can be a 10-15 year process, medical device development often has a more defined and potentially faster regulatory path.

Value-based Care: These technologies align with the shift toward value-based care by offering solutions that can improve patient outcomes and reduce long-term healthcare costs.

🤝 Strategic Acquisitions

The electric medicine trend is also fueling strategic acquisitions as larger medical device companies seek to expand their portfolios and stay competitive. Instead of focusing on incremental improvements to existing products, companies are acquiring smaller, innovative startups to gain access to new technologies and expand into high-growth markets.

Recent strategic acquisitions in the medtech space include:

Johnson & Johnson's acquisition of Abiomed for its heart pump technology and Shockwave Medical for its cardiovascular devices.

Stryker's acquisition of Inari Medical for its vascular clot removal solutions.

Boston Scientific's acquisition of Relievant Medsystems for its pain management solutions and Axonics for its sacral neuromodulation systems.

These acquisitions are driven by a need to integrate new technologies, strengthen product portfolios, and position companies as leaders in emerging fields like electrophysiology, neuromodulation, and vascular health. This M&A activity is expected to continue as the market for electric medicine and related healthtech solutions expands.

To discuss how Nelson Advisors can help your HealthTech or MedTech company, please email [email protected]